Fuchs' Endothelial Dystrophy Treatment in India
- Top Accredited Hospitals
- Global Medical Standards
- Cutting-Edge Technology
- Proven Treatment Options
- High Success Rate
- Trusted by Millions
What is Fuchs' endothelial dystrophy?
Fuchs endothelial dystrophy is a condition that causes vision problems. It is a type of posterior corneal dystrophy that affects the innermost layer of corneal endothelial cells and Descemet’s membrane (the basement membrane). It leads to loss of corneal endothelial cells, causing fluid buildup (oedema) and the formation of small bumps called guttata, which decreases visual clarity.
What is the Importance of Timely Treatment?
Timely treatment of Fuchs dystrophy is critical to prevent permanent visual loss and avoid invasive surgery. Early intervention can lead to faster recovery, lower rejection risk, and better outcomes, such as fewer painful blisters and less morning vision loss.
What are the common symptoms of Fuchs' endothelial dystrophy?
Symptoms and their intensity can vary depending on the condition. The following describes the symptoms associated with the disease.
- Reduced corneal clarity
- Eye movement-induced pain
- Impaired vision at night or in low light
- Reduced visual acuity (decreased central vision)
- Cloudiness
- Redness and swelling
- Glare or sensitivity to light
- Blurred vision
Causes and Risk Factors of Fuchs' Endothelial Dystrophy
Causes
- TCF4 gene changes: Changes in the TCF4 gene are particularly associated with Fuchs’ endothelial dystrophy. These changes can produce abnormal RNA that interferes with normal corneal endothelial cell function.
- COL8A2 mutations: Changes in the COL8A2 gene are linked to early-onset forms of Fuchs’ endothelial dystrophy and may cause corneal changes at a younger age.
- Other genes: Changes in genes and other factors may also increase the risk of developing FED in some people.
Risk Factors
- Age: The earliest signs of Fuchs’ dystrophy may be visible in people in their 30s and 40s. But the disease usually affects vision after age 50.
- Sex: Research shows evidence that females are at higher risk than males.
- Family history: It is more common in people with a biological family history, which increases risk.
- Smoking: It increases oxidative stress, which can damage corneal endothelial cells.
- Previous eye surgery: Procedures like cataract surgery can put extra strain on corneal cells, especially in people who are already at risk.
- UV exposure: Long-term ultraviolet exposure may cause small deposits called guttae to form in the cornea.
- Hormonal: Hormonal factors may also influence FED progression, as the condition is more prevalent in postmenopausal women, which is linked to estrogen deficiency
Latest Research and Technologies in the Treatment of Fuchs' Endothelial Dystrophy in India
- Newer approaches, including DWEK (Descemetorhexis without endothelial keratoplasty) combined with ROCK inhibitors and improved DMEK (Descemet Membrane Endothelial Keratoplasty) techniques, are being studied to support corneal healing and improve surgical outcomes. Researchers are also exploring regenerative treatments, including gene therapies and gene editing.
Treatment options for Fuchs' Endothelial Dystrophy
Inner corneal transplant: Descemet membrane endothelial keratoplasty, or DMEK, is a surgical procedure in which the back layer of the cornea is replaced with healthy endothelial cells from a donor.
Cornea transplant: If you previously had eye surgery, an eye care professional may suggest a partial-thickness cornea transplant, known as Descemet-stripping endothelial keratoplasty, or DSEK. In rare cases, you may need a complete cornea transplant, known as penetrating keratoplasty (PK).
Cost Start From 2000Explore Options
- Clinical assessment:
- Eye examination: Clinical assessment involves a comprehensive eye examination and a detailed clinical evaluation of the condition, followed by a medical history and physical examination
- Slit-lamp examination: Performed to look for changes in the corneal structure, particularly bumps called guttata and corneal swelling. Visual ability is also checked to see how the condition affects vision.
- Imaging Tests:
- Specular microscopy: Examines the endothelial cells and assesses their number, size, and shape.
- Pachymetry: It measures the corneal thickness to track fluid accumulation
- Optical tomography: A noninvasive imaging method that uses images of the back of your eye using reflected light.
- Lubricating eye drops and preservative-free artificial tears minimise ocular surface irritation and discomfort from corneal oedema. Topical steroids and mild anti-inflammatories may reduce endothelial oxidative stress, leading to transient improvements in corneal clarity. However, long-term use requires monitoring.
Instantly Connect with our Specialists
Hospitals for Fuchs' Endothelial Dystrophy in India
Apollo Hospitals
Hyderabad, India
Apollo Hospitals located in Hyderabad, India is accredited by JCI, NABH. Also listed below are some of the most prominent infrastructural details:
- A premier multi-specialty hospital with 477-bed capacity
- More than 50 specialties, super-specialties
- 12 Centers of Excellence
- The Institutes for Heart Diseases, Neurosciences, Cancer, Emergency, Orthopaedics, Renal Diseases, and Transplants
- Centers of Excellence are known for patient care, training and research
- Doctors with years of truly global experience in healthcare delivery
Artemis Health Institute
Gurgaon, India
Artemis Hospital, established in 2007 in Gurgaon, India, is a 750+ bed, state-of-the-art multi-speciality hospital and the first in Gurgaon accredited by JCI and NABH. A flagship of the Apollo Tyres Group, it offers advanced care across cardiology, oncology, orthopaedics, neurology, and transplant medicine, supported by modern infrastructure and 60+ world-class operating theatres. Its Centres of Excellence span critical areas like heart, cancer, neurosciences, orthopaedics, and women & child care. Guided by values of Service, Compassion, and Integrity, Artemis combines innovation, technology, and affordability, making it a trusted international healthcare destination for comprehensive and compassionate patient care.
Marengo Asia Hospitals, Faridabad
Faridabad, India
Marengo Asia Hospitals, located in Faridabad, is a multispecialty, state-of-the-art, and patient-friendly facility that combines the greatest services available in the healthcare segment. With 325 beds now, the hospital can accommodate up to 550 beds. It has first-rate medical facilities including a Critical Care Medicine department for patients with life-threatening conditions. Furthermore, our highly skilled medical staff and cutting-edge software system make us the perfect facility for patients from various backgrounds. We always aim to exceed expectations and are always looking for ways to boost our performance.
Our Services to better your experience
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Why Choose India for Fuchs' Endothelial Dystrophy Treatment?
- Specialised corneal surgeons: major eye centres have highly experienced corneal and endothelial disorder specialists and world-renowned, dedicated eye centres.
- Advanced procedures: Selected centres perform DMEK and DSAEK, which replace the damaged endothelial layer while preserving most of the patient's cornea.
- Modern diagnostic testing: Patients may have access to specular microscopy, corneal tomography, pachymetry, and anterior-segment OCT to support diagnosis and treatment planning.
- Access to newer approaches: Indian centres are also involved in research on the latest approaches.
- Telemedicine service: Telemedicine services and AI-powered diagnostics improve access, making India a leading destination for corneal transplants at a fraction of the cost without compromising quality.